Eligibility Coronary Artery Disease NCT01655524

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
Descripción

ID.1

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide an informed consent
Descripción

ID.2

Tipo de datos

boolean

known allergic reaction to aminophylline or regadenoson
Descripción

ID.3

Tipo de datos

boolean

systolic blood pressure < 90 mmhg
Descripción

ID.4

Tipo de datos

boolean

unstable abnormal heart rhythm
Descripción

ID.5

Tipo de datos

boolean

pulmonary edema
Descripción

ID.6

Tipo de datos

boolean

acute coronary symptoms, myocardial infarction within 48 hours
Descripción

ID.7

Tipo de datos

boolean

active dipyridamole, aminophylline or theophylline use
Descripción

ID.8

Tipo de datos

boolean

pregnancy
Descripción

ID.9

Tipo de datos

boolean

any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Coronary Artery Disease NCT01655524

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
inability to provide an informed consent
boolean
ID.3
Item
known allergic reaction to aminophylline or regadenoson
boolean
ID.4
Item
systolic blood pressure < 90 mmhg
boolean
ID.5
Item
unstable abnormal heart rhythm
boolean
ID.6
Item
pulmonary edema
boolean
ID.7
Item
acute coronary symptoms, myocardial infarction within 48 hours
boolean
ID.8
Item
active dipyridamole, aminophylline or theophylline use
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
boolean